Vanguard Group
MDXG icon

Vanguard Group’s MiMedx Group MDXG Stock Holding History

Vanguard Group’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$48.6M Buy
7,184,262
+382,623
+6% +$2.68M ﹤0.01% 2173
2025
Q3 		$47.5M Sell
6,801,639
-155,611
-2% -$1.08M ﹤0.01% 2182
2025
Q2 		$42.5M Buy
6,957,250
+246,160
+4% +$1.64M ﹤0.01% 2206
2025
Q1 		$51M Buy
6,711,090
+5,457
+0.1% +$45.6K ﹤0.01% 2089
2024
Q4 		$64.5M Sell
6,705,633
-262,667
-4% -$2.05M ﹤0.01% 2055
2024
Q3 		$41.2M Buy
6,968,300
+42,794
+0.6% +$283K ﹤0.01% 2263
2024
Q2 		$48M Buy
6,925,506
+1,002,782
+17% +$7.05M ﹤0.01% 2159
2024
Q1 		$45.6M Sell
5,922,724
-644,530
-10% -$5.18M ﹤0.01% 2214
2023
Q4 		$57.6M Buy
6,567,254
+130,099
+2% +$953K ﹤0.01% 2125
2023
Q3 		$46.9M Buy
6,437,155
+250,812
+4% +$1.87M ﹤0.01% 2160
2023
Q2 		$40.9M Buy
6,186,343
+86,890
+1% +$443K ﹤0.01% 2277
2023
Q1 		$20.8M Buy
6,099,453
+4,858
+0.1% +$18.8K ﹤0.01% 2569
2022
Q4 		$16.9M Buy
6,094,595
+75,937
+1% +$227K ﹤0.01% 2706
2022
Q3 		$17.3M Buy
6,018,658
+1,349,728
+29% +$4.8M ﹤0.01% 2697
2022
Q2 		$16.2M Buy
4,668,930
+118,172
+3% +$463K ﹤0.01% 2748
2022
Q1 		$21.4M Buy
4,550,758
+50,182
+1% +$245K ﹤0.01% 2734
2021
Q4 		$27.2M Buy
4,500,576
+272,564
+6% +$1.89M ﹤0.01% 2676
2021
Q3 		$25.6M Sell
4,228,012
-197,363
-4% -$2.22M ﹤0.01% 2710
2021
Q2 		$55.4M Buy
4,425,375
+303,824
+7% +$3.29M ﹤0.01% 2314
2021
Q1 		$42.5M Buy
4,121,551
+62,136
+2% +$600K ﹤0.01% 2405
2020
Q4 		$36.9M Buy
+4,059,415
New +$29.2M ﹤0.01% 2354
2018
Q4 		– Sell
-8,610,148
Closed -$53.2M – 4154
2018
Q3 		$53.2M Buy
8,610,148
+864,031
+11% +$3.91M ﹤0.01% 2107
2018
Q2 		$49.5M Sell
7,746,117
-832,190
-10% -$5.92M ﹤0.01% 2136
2018
Q1 		$59.8M Buy
8,578,307
+635,670
+8% +$7.4M ﹤0.01% 1985
2017
Q4 		$100M Buy
7,942,637
+380,937
+5% +$4.65M ﹤0.01% 1721
2017
Q3 		$89.8M Buy
7,561,700
+1,900,589
+34% +$28.2M ﹤0.01% 1769
2017
Q2 		$84.7M Buy
5,661,111
+566,114
+11% +$7.55M ﹤0.01% 1764
2017
Q1 		$48.6M Buy
5,094,997
+73,891
+1% +$624K ﹤0.01% 2025
2016
Q4 		$44.5M Buy
5,021,106
+152,895
+3% +$1.37M ﹤0.01% 2032
2016
Q3 		$41.8M Buy
4,868,211
+118,169
+2% +$936K ﹤0.01% 2014
2016
Q2 		$37.9M Buy
4,750,042
+218,072
+5% +$1.7M ﹤0.01% 2023
2016
Q1 		$39.6M Buy
4,531,970
+73,209
+2% +$608K ﹤0.01% 1974
2015
Q4 		$41.8M Buy
4,458,761
+339,317
+8% +$2.94M ﹤0.01% 1963
2015
Q3 		$39.8M Buy
4,119,444
+351,606
+9% +$3.71M ﹤0.01% 1981
2015
Q2 		$43.7M Buy
3,767,838
+718,808
+24% +$7.4M ﹤0.01% 2006
2015
Q1 		$31.7M Buy
3,049,030
+222,720
+8% +$2.08M ﹤0.01% 2132
2014
Q4 		$32.6M Buy
2,826,310
+152,951
+6% +$1.51M ﹤0.01% 2033
2014
Q3 		$19.1M Buy
2,673,359
+79,660
+3% +$555K ﹤0.01% 2223
2014
Q2 		$18.4M Buy
2,593,699
+151,495
+6% +$887K ﹤0.01% 2246
2014
Q1 		$15M Buy
2,442,204
+279,331
+13% +$2.05M ﹤0.01% 2297
2013
Q4 		$18.9M Buy
2,162,873
+343,754
+19% +$2.1M ﹤0.01% 2190
2013
Q3 		$7.59M Buy
1,819,119
+2,321
+0.1% +$12.8K ﹤0.01% 2525
2013
Q2 		$12.8M Buy
+1,816,798
New +$12.7M ﹤0.01% 2228

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group's MDXG Position: Q4 2025 in Review

Vanguard Group increased its MiMedx Group (MDXG) stake by 5.6% in Q4 2025, buying an estimated $2.68M and bringing the position to 7,184,262 shares worth $48.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2173.

Vanguard Group first reported a position in MDXG in Q2 2013 and has held it in 43 quarters since. The position peaked at $100M in Q4 2017. 233 funds tracked by Wall St. Rank hold MDXG as of Q4 2025.

  • Vanguard Group held 7,184,262 shares of MiMedx Group worth $48.6M as of Q4 2025.
  • Vanguard Group bought 382,623 MiMedx Group shares in Q4 2025, an estimated $2.68M.
  • MiMedx Group made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2173 holding.
  • Vanguard Group first reported a position in MiMedx Group in Q2 2013 and has held it in 43 quarters since.
  • Vanguard Group's MiMedx Group position peaked at $100M in Q4 2017.
  • 233 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.